Detalhe da pesquisa
1.
Prostate cancer in transgender women: considerations for screening, diagnosis and management.
Br J Cancer
; 128(2): 177-189, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261584
2.
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 28(4): 366-e224, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519763
3.
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.
Int J Mol Sci
; 24(19)2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37834162
4.
Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings.
Prostate
; 81(10): 657-666, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978244
5.
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
Cancer
; 127(13): 2204-2212, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765337
6.
Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes.
CA Cancer J Clin
; 62(5): 299-308, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22535487
7.
Management of Atypical Renal Cell Carcinomas.
Curr Treat Options Oncol
; 18(10): 61, 2017 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28913767
8.
Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer.
Oncologist
; 21(12): 1414-e9, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742908
9.
A robust blood gene expression-based prognostic model for castration-resistant prostate cancer.
BMC Med
; 13: 201, 2015 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26297150
10.
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease.
J Urol
; 194(1): 91-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623747
11.
Is prostate cancer changing?: evolving patterns of metastatic castration-resistant prostate cancer.
Cancer
; 120(6): 833-9, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25302607
12.
Phase Ib/II trial of gemcitabine, cisplatin, and lenalidomide as first-line therapy in patients with metastatic urothelial carcinoma.
Oncologist
; 19(9): 915-6, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052451
13.
Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials.
Clin Genitourin Cancer
; : 102066, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584004
14.
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy.
Am J Clin Oncol
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344754
15.
Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States.
World J Urol
; 31(5): 1211-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22622394
16.
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis.
World J Urol
; 31(6): 1535-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23223962
17.
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors.
J Cancer Res Clin Oncol
; 149(7): 2833-2841, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788726
18.
Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy.
Cancer
; 118(23): 5947-54, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22707387
19.
Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC).
BJU Int
; 110(11): 1580-8, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22985411
20.
Overcoming castration resistance in prostate cancer.
Curr Opin Urol
; 22(3): 167-74, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22472508